MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Combined hormonal contraception (community and hospital)

Drug Safety Updates

 April 2008: Hormonal contraceptives: cervical cancer

 February 2014: Combined hormonal contraceptives and venous thromboembolism: review confirms risk is small

 March 2014: Combined hormonal contraceptives: risk of venous thromboembolism

 March 2014: St John’s wort: interaction with hormonal contraceptives, including implants

contains ethinylestradiol 2.7mg + etonogestrel 11.7mg

Pack Price
3 system £23.76